Sunmax Biotechnology Co Ltd Capital Reinvestment Ratio

Latest as of September 2025: 0.11x

Sunmax Biotechnology Co Ltd capital reinvestment ratio. Sunmax Biotechnology Co Ltd (4728) has a Capital Reinvestment Ratio of 0.11x as of September 2025, meaning it reinvests 0% of its operating cash flow (NT$160.84 Million) in capital expenditures (NT$17.44 Million). Check Sunmax Biotechnology Co Ltd (4728) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.11x
Capex / Operating Cash Flow

Operating Cash Flow

NT$160.84 Million
TWD

Capital Expenditures

NT$17.44 Million
TWD

Data as of

Sep 2025
Most recent filing

Capital Reinvestment Ratio of Sunmax Biotechnology Co Ltd (2016–2024)

Capital reinvestment ratio of Sunmax Biotechnology Co Ltd from 2016 to 2024. This chart tracks Sunmax Biotechnology Co Ltd's Capital Reinvestment Ratio across 9 annual periods. Also explore Sunmax Biotechnology Co Ltd net asset momentum to track the company's year-over-year net asset growth rate.

Sunmax Biotechnology Co Ltd Capital Reinvestment Ratio by Year (2016–2024)

Sunmax Biotechnology Co Ltd capital reinvestment ratio by year from 2016 to 2024. For the full cash flow conversion analysis, see Sunmax Biotechnology Co Ltd (4728) cash flow conversion.

Year Reinvestment Ratio Operating CF (TWD) Capital Expenditures YoY Change
2024 0.09x NT$397.37 Million NT$36.61 Million ▼ -29.2%
2023 0.13x NT$848.56 Million NT$110.39 Million ▼ -70.7%
2022 0.44x NT$342.97 Million NT$152.03 Million ▼ -57.8%
2021 1.05x NT$243.28 Million NT$255.43 Million ▲ +212.3%
2020 0.34x NT$386.97 Million NT$130.10 Million ▲ +611.3%
2019 0.05x NT$289.51 Million NT$13.68 Million ▲ +1.0%
2018 0.05x NT$100.83 Million NT$4.72 Million ▼ -45.0%
2017 0.09x NT$37.09 Million NT$3.15 Million ▼ -70.2%
2016 0.29x NT$16.58 Million NT$4.73 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow